To accelerate cancer prevention in Europe: Challenges for cancer registries
- PMID: 30352383
- DOI: 10.1016/j.ejca.2018.09.001
To accelerate cancer prevention in Europe: Challenges for cancer registries
Abstract
The availability of population-based cancer registry (CR) data is paramount in the development of modern oncology. Major contributions consisted in accurately measuring cancer burden (incidence, survival and prevalence, beside mortality), identifying and quantifying risk factors (case control and cohort studies that, in the last two decades, included gene variant assessment) and evaluating outcomes of treatments and preventive interventions, including mass screening. Cancer registration coverage of European populations progressed slowly since 1940 and is now almost 50%. Areas lacking high-quality national population-based cancer registration still exist within large countries such as France, Italy, Romania and Spain, Germany and Poland having national plans and legislation to reach complete coverage. Depending on programme ownership, history and institutional organisation, European CRs showed huge variations in the scope (research domain), size, available resources and finally exploitation of collected data. This reflects their heterogeneous origins stemming from different professional backgrounds and healthcare systems. This review discusses not only the potential for contributing to acceleration of prevention but also the coverage expansion by and innovation of CR organizations. The latter can be attained not only by more standardisation in institutional organisation and operative methodologies but also by intensification of scientific production and risk communication. The CR's agenda should focus on cancers caused by identifiable risk factor(s) that are amenable to preventive actions, including early detection; short-term priorities usually are with tobacco, and medium-term priorities are with alcohol, occupational exposures, infection-related cancers and ultraviolet-related skin cancers, while obesity-related cancers are likely to increase gradually further in the long term.
Keywords: Cancer burden; Cancer registration; Data innovation; Europe; Preventive interventions.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.Eur J Cancer. 2015 Jun;51(9):1050-63. doi: 10.1016/j.ejca.2015.02.017. Epub 2015 Apr 29. Eur J Cancer. 2015. PMID: 25934439
-
EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.Eur J Cancer. 2015 Jun;51(9):997-1017. doi: 10.1016/j.ejca.2015.02.018. Epub 2015 May 5. Eur J Cancer. 2015. PMID: 25956208
-
Cancer registries in Europe-going forward is the only option.Ecancermedicalscience. 2016 May 12;10:641. doi: 10.3332/ecancer.2016.641. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27350787 Free PMC article. Review.
-
Cancer prevention in the Asia Pacific region.Asian Pac J Cancer Prev. 2010;11(4):839-44. Asian Pac J Cancer Prev. 2010. PMID: 21133587 Review.
Cited by
-
Effectiveness of Network Relations in Poland during the Economic Crisis Caused by COVID-19: Interorganizational Network Viewpoints.Int J Environ Res Public Health. 2023 Jan 9;20(2):1178. doi: 10.3390/ijerph20021178. Int J Environ Res Public Health. 2023. PMID: 36673933 Free PMC article.
-
Understanding the global impact of primary brain tumors: The untapped potential of population-based cancer registries.Neuro Oncol. 2021 Oct 1;23(10):1625-1626. doi: 10.1093/neuonc/noab165. Neuro Oncol. 2021. PMID: 34244769 Free PMC article. No abstract available.
-
Trend and Joinpoint Analysis of Cancer Incidence and 1-Year Mortality in North-East Spain 2005-2020.Cancers (Basel). 2023 Nov 22;15(23):5527. doi: 10.3390/cancers15235527. Cancers (Basel). 2023. PMID: 38067232 Free PMC article.
-
Cancer treatment data available in European cancer registries: Where are we and where are we going?Front Oncol. 2023 Feb 8;13:1109978. doi: 10.3389/fonc.2023.1109978. eCollection 2023. Front Oncol. 2023. PMID: 36845700 Free PMC article.
-
Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma.Clin Epidemiol. 2023 Sep 18;15:987-999. doi: 10.2147/CLEP.S413587. eCollection 2023. Clin Epidemiol. 2023. PMID: 37745645 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources